How to judge a startup ramp: MedPal's GLP-1 clinic

A founder or investor looking at MedPal's September update has to decide whether a fast ramp is durable. The company reported about £3.2 million in group revenue. Its shares were down 14% at 5.90 pence in London on Tuesday afternoon. The update gives enough detail to run the test.

The useful question is whether the growth is carried by customers who come back, or by a one-time surge of first orders. For founders and investors, that question becomes a ramp-credibility test: monthly revenue, repeat and recurring share, repeat AOV versus first AOV, order velocity, and working-capital capacity.

Start with the month, not the run rate

MedPal's annualised run rate was over £38 million, up from over £35 million on 21 September and from about £28 million in August. A run rate multiplies a recent month and assumes it repeats, so the first check is the actual month against the prior month. The monthly number is the anchor; if the prior month is missing, the ramp is hard to judge.

When the run rate jumps faster than the monthly number, look at the last few days. Daily revenue in the final 11 days of September was about 50% higher than daily revenue in the first 19 days. That pattern can be real acceleration, a launch spike, a marketing push, or a one-off batch of orders.

Ask for monthly revenue by product line, not just the group total. The answer should separate the line driving the month from the line that is merely stable, and show the prior month for the same line. A product-line split also reveals whether the group total is being lifted by a new line while the older line stalls.

Separate the first-order surge from the repeat base

MedPal's New Health business generated more than £2.7 million in September from over 22,600 orders, about 50% above August's £1.8 million. That is a large top-line move, but it does not by itself show whether customers will return.

The more telling number is the share of revenue already coming from returning customers or committed usage. MedPal attributed over £1 million, about one-third of its September group revenue, to repeat orders from New Health, NHS prescriptions, and subscriptions. The repeat slice matters because it is the part of revenue that has already survived the first-order decision. If that slice is small while first orders surge, the ramp may be a customer-acquisition story rather than a retention story.

Compare repeat AOV with first-order AOV. A clean answer shows repeat orders at least as large as first orders, or at least that the repeat base is not being carried by low-value refills. Also request the repeat share by customer type, not just by revenue, so subscriptions, prescriptions, and repeat orders are separated and one line cannot mask weakness in another.

Watch order velocity and capacity against working capital

Order velocity tells you whether the business can keep filling the demand it has created. MedPal said the enlarged GLP-1 line at Sarus Court was expected to begin operating by late October, raising capacity to 14,000 orders per day.

Match the new capacity to the current order flow, and see whether the next month's revenue is constrained by demand or by operations. Pull the order count by day, not just by month, so you can tell whether velocity is rising through the month or spiking around a launch. If daily orders are already near the old limit, the next month may be capped by operations even if demand continues.

Working capital is where a fast ramp can break. Inventory, payment terms, and clinic costs come due before revenue settles. If the company must keep raising money to fund the next batch of orders, the growth has a dilution cost.

Pull the cash needed to hold inventory, pay suppliers, and cover clinic costs before customer payments arrive. The check passes when you can see whether the company has enough runway to absorb a slower month. The test is whether it can carry the gap between paying for stock and receiving payment from customers.

Before trusting a run rate, run the ramp-credibility test:

• Monthly revenue, with the prior month for the same product line
• Repeat or recurring share of revenue
• Repeat AOV versus first-order AOV
• Order velocity by day, matched to capacity
• Working-capital capacity to absorb a slower month